BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6937966)

  • 1. Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report.
    Perera MR; Amirak ID; Noone P
    Scand J Infect Dis Suppl; 1980; Suppl 23():186-8. PubMed ID: 6937966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose netilmicin therapy of severe or chronic infections.
    Hellum KB; Madsen ST; Digranes A; Stokstad S; Solberg CO
    Scand J Infect Dis Suppl; 1980; Suppl 23():189-94. PubMed ID: 6937967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netilmicin in urinary tract infections.
    Svare J; Johnsen NJ; Vesterhauge S; Lund F; Thomsen J; Vejlsgaard R
    Scand J Infect Dis Suppl; 1980; Suppl 23():132-4. PubMed ID: 6937957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection.
    Bubrick MP; Howard RJ; Pancorbo S; Lorber RR; Chin TW; Yost R
    Clin Ther; 1983; 5(5):515-24. PubMed ID: 6352035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates.
    Peitersen B; Hørlyk H; Nielsen M; Prag J; Korner B; Heilesen AM; Friis-Møller A
    Scand J Infect Dis Suppl; 1980; Suppl 23():151-4. PubMed ID: 6937961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
    Buckwold FJ; Ronald AR; Lank B; Thompson L; Fox L; Harding GK
    Can Med Assoc J; 1979 Jan; 120(2):161-7. PubMed ID: 761144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of netilmicin, 150 mg BID, in systemic infections.
    Tambic T; Kropec I; Kosuta D
    Clin Ther; 1981; 4(1):43-7. PubMed ID: 7023679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netilmicin therapy of patients with septicaemia and other severe infections.
    Brandenhoff P; Stafanger G; Gammelgaard PA; Rasmussen F; Jensen SH; Bretlau P; Thomsen VF
    Scand J Infect Dis Suppl; 1980; Suppl 23():181-5. PubMed ID: 6937965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
    Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
    Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.
    Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R
    J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.
    Herting RL; Lorber RR; Miller M; Danzig MR
    Arzneimittelforschung; 1981; 31(2):366-70. PubMed ID: 7194655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netilmicin in the treatment of neonates with moderate and severe infections.
    Michalsen H; Halvorsen K; Bergan T
    Scand J Infect Dis Suppl; 1980; Suppl 23():146-50. PubMed ID: 6937960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.
    Nordström L; Christensson P; Haeger K; Juhlin I; Tjernström O; Wallmark E
    J Int Med Res; 1979; 7(2):117-26. PubMed ID: 478159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netilmicin use in pediatric patients.
    Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
    Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin therapy administered by intermittent intravenous injections.
    Korner B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:15-2. PubMed ID: 4521603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.